6 completed. 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow kalinox: new trials by email Literature Review of kalinox trials Research Report on kalinox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brain Reactivity to Nitrous Oxyde in Depression : an MRI and Ultrasound Study (PROTOBRAIN Pilote) Nitrous Oxide-Oxygen, Tissue Pulsatility Imaging - TPI, Magnetic Resonance Imaging - MRI - Treatment Resistant Depression, Nitrous Oxyde | Not applicable | Completed | University Hospital, Tours | 30 | 2020-02-20 | 2025-12-23 |
| Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients formal hypnosis, Kalinox - Cancer, Brachytherapy | Phase 2 | Completed | Institut de Cancérologie de Lorraine | 68 | 2019-11-02 | 2026-09-01 |
| Interest of Virtual Reality in the Management of Anxiety and Pain Related to Post-cardiac Surgery Care Virtual Reality, Kalinox - Surgery, Cardiac | Not applicable | Completed | CMC Ambroise Paré | 200 | 2019-09-26 | 2026-04-08 |
| Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH) Virtual Reality, Kalinox - Hematologic Neoplasms | Phase 2 / Phase 3 | Completed | Weprom | 126 | 2018-09-06 | 2020-06-23 |
| Hyperalgesia and Pain Nitrous Oxide - Hyperalgesia | Phase 1 | Completed | Air Liquide Santé International | 20 | 2012-01-01 | 2025-09-11 |
| Efficacy of Premixed Nitrous Oxide and Oxygen in Patient With Out-of-hospital Moderate Acute Pain Premixed 50% nitrous oxide and oxygen (Kalinox), medical air - Acute Pain | Phase 4 | Completed | University Hospital, Toulouse | 60 | 2010-02-01 | 2017-05-12 |
Pain (2) · Acute Pain (1) · Anxiety Disorders (1) · Depressive Disorder, Treatment-Resistant (1) · Hematologic Neoplasms (1) · Hyperalgesia (1) · Neoplasms (1)
Air Liquide Santé International (1) · CMC Ambroise Paré (1) · Institut de Cancérologie de Lorraine (1) · University Hospital, Toulouse (1) · University Hospital, Tours (1) · Weprom (1)
France (5) · Germany (1)
Katell LE DU, MD (1)
PMID 23406077, PMID 33983498, PMID 34735395, PMID 36790852, PMID 37592013, PMID 40883194
2018 (1)